FEI Co.
FEIC
NASDAQ106.89
USD
+0.01
- -
CIK
0000914329
Return %
Stock
S&P500
1Y
- -
26.53
3Y
- -
76.60
5Y
- -
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Technology
- Industry
- Hardware, Equipment & Parts
- Address
- IPO Date
- May 31, 1995
- CIK
- 0000914329
- Similar Companies
- Business
- FEI Company designs, manufactures, and supports high-performance electron microscopy and focused charged particle beam technology products used for imaging and analysis at micro-, nano-, and picometer scales. Its core offerings include focused ion beam systems, scanning electron microscopes, transmission electron microscopes, and associated software and services that serve the semiconductor, materials science, life sciences, and industrial research markets globally. Founded in 1971 and headquartered in Hillsboro, Oregon, FEI operates sales and service operations in over 50 countries. The company was acquired by Thermo Fisher Scientific in early 2017 and subsequently integrated as the Materials & Structural Analysis division of Thermo Fisher. Since the acquisition, FEI has expanded its capabilities and product portfolio under Thermo Fisher’s Analytical Instruments Segment, strengthening its presence in semiconductor and materials research markets. Its service business, representing about 25% of FEI’s revenue, supports customers worldwide with high-margin recurring revenues. Recent strategic expansions have focused on accelerating innovation in nanoscale imaging and enhancing customer productivity through integrated hardware and software workflow solutions. FEI serves diverse industries including semiconductor manufacturing, pharmaceuticals, biotechnology, nanotechnology, and academic research, providing advanced microscopy and analysis solutions necessary for cutting-edge material characterization and device development. Its acquisition by Thermo Fisher Scientific marks a significant operational change, positioning FEI’s technology offerings within a larger scientific instrument platform to leverage a broader biopharma and industrial customer base globally. The company employs over 2,800 staff worldwide, emphasizing innovation and comprehensive customer support across its geographic footprint.